Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Neurasthenia: history and the present

Full Text:


The paper provides a historical analysis of the concept of neurasthenia with emphasis on its psychopathological heterogeneity. It considers predisposing and initiating factors in the genesis of neurasthenia. Particular emphasis is placed on its differential pharmacotherapy, by keeping in mind its predisposing factors. The results of studies confirming the efficacy of Tanakan® in different types of this abnormality are given.

About the Author

D. Yu. Veltishchev
Moscow Research Institute of Psychiatry, Ministry of Health and Social Development of the Russian Federation
Russian Federation


1. <div><p>Морозов В.М. Малая психиатрия. Психогении – неврозы (лекция). Психиатр и психофармакотер 2011;1:5–10.</p><p>Costa e Silva J.A., De Girolamo G. Neurasthenia: history of a concept. In: Psychological disorders in general medical setting. N. Sartorius, D. Goldberg, G. de Girolamo, J. Costa e Silva, Y. Lecrubier, and U. Wittchen (eds.). Bern: Hogrefe and Huber, 1990;69–81.</p><p>Goering L. Russian nervousness: Neurasthenia and national identity in nineteenthcentury Russia. J Hist Med 2003;47:23–46.</p><p>Ковалевский П.И. Психиатрические эскизы из истории. В двух томах. М.: Терра, 1995;554 с.</p><p>Ковалевский П.И. Folie du doute. Архив психиатрии, неврологии и судебной психопатологии 1886;36–57.</p><p>Sicherman B. The uses of a diagnosis: doctors, patients and neurasthenia. J Hist Med 1997;32:33–54.</p><p>Merikangas K., Angst J. Neurasthenia in a longitudinal cohort study of young adults. Psychol Med 1994;24:1013–24.</p><p>Ьstь n T.B. and Sartorius N. Mental illness in general health care: an international study. Chichester: Wiley, 1995.</p><p>World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: WHO, 1992.</p><p>Краснов В.Н., Вельтищев Д.Ю. Неврастения как вариант астенического синдрома: фармакотерапевтический анализ на модели терапии танаканом. Журн неврол и психиатр 1999;99(7):37–40.</p><p>Вельтищев Д.Ю. Аффективная модель стрессовых расстройств: психическая травма, ядерный аффект и депрессивный спектр. Соц и клин психиатр 2006;16(3):104–9.</p><p>Birks J., Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. The Cochrane Database of Systematic Reviews 2002;4.</p><p>Cieza A., Maier P., Poeppel E. Effects of Ginkgo biloba on mental functioning in healthy volunteers. Arch Med Res 2003;34:373–81.</p><p>Eckmann F., Schlag H. Kontrollierte Doppelblind-Studie zum Wirksamkeitsnachweis von Tebonin forte bei Patienten mit zerebrovaskua Ёrer Insuffizienz. Fortschr Med 1982;100:1474–8.</p><p>Hoerr R. Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761. Pharmacopsychiatry 2003;36(Suppl. 1): S56–S61.</p><p>Le Bars P.L., Katz M.M., Berman N. et al. North American EGb Study Group. A placebocontrolled, double-blind randomized trial of an extract of Ginkgo biloba for dementia. J Am Med Assoc 1997;278:1327–32.</p><p>Mix J.A., Crews W.D. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Hum Psychopharm Clin Exp 2002;17:267–77.</p><p>Oken B.S., Storzbach D.M., Kaye J.A. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998;55:1409–15.</p><p>Jezova D., Duncko R., Lassanova M. et al. Reduction of rise in blood pressure and cortisol release during stress by Ginkgo biloba extract (EGb 761) in healthy volunteers. J Physiol Pharmacol 2002;53:337–48.</p><p>Marcilhac A., Dakine N., Bourhim N. et al. Effect of chronic administration of Ginkgo biloba extract or ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat. Life Sci 1998;62:2329–40.</p><p>Porsolt R.D., Martin P., Fromage S. et al. Anti-stress effects of EGb 761 in rodent models. In: Y. Cristen, J. Costentin, M. Lacour (eds). Effects of Ginkgo biloba extract (EGb 761) on the central nervous system. Elsevier,1992;135–45.</p><p>Rapin J.R., Lamproglou I., Drieu K. Demonstration of the ≪anti-stress≫ activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task. Gen Pharmacol 1994;25:1009–16.</p><p>Ward C.P., Redd K., Williams B.M. et al. Ginkgo biloba extract: cognitive enhancer of antistress buffer. Pharmacol Biochem Behav 2002;72:913–22.</p><p>Незнамов Г.Г., Телешова Е.С., Сюняков С.А. и др. Влияние танакана на психофизиологическое состояние больных с астеническими расстройствами. Экспер клин психофармакол 2002;1:22–8.</p></div><br />


For citations:

Veltishchev D.Yu. Neurasthenia: history and the present. Neurology, Neuropsychiatry, Psychosomatics. 2011;3(4):9-13. (In Russ.)

Views: 841

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)